Search Results

There are 23856 results for: content related to: Differential gene expression of CYP3A isoforms in equine liver and intestines

  1. You have free access to this content
    P-glycoprotein and cytochrome P450 3A act together in restricting the oral bioavailability of paclitaxel

    International Journal of Cancer

    Volume 132, Issue 10, 15 May 2013, Pages: 2439–2447, Jeroen J.M.A. Hendrikx, Jurjen S. Lagas, Hilde Rosing, Jan H.M. Schellens, Jos H. Beijnen and Alfred H. Schinkel

    Version of Record online : 14 NOV 2012, DOI: 10.1002/ijc.27912

  2. You have free access to this content
    Effects of cytochrome P450 3A (CYP3A) and the drug transporters P-glycoprotein (MDR1/ABCB1) and MRP2 (ABCC2) on the pharmacokinetics of lopinavir

    British Journal of Pharmacology

    Volume 160, Issue 5, July 2010, Pages: 1224–1233, RAB van Waterschoot, R ter Heine, E Wagenaar, CMM van der Kruijssen, RW Rooswinkel, ADR Huitema, JH Beijnen and AH Schinkel

    Version of Record online : 22 MAR 2010, DOI: 10.1111/j.1476-5381.2010.00759.x

  3. Cloning, sequencing, heterologous expression, and characterization of murine cytochrome P450 3a25*(Cyp3a25), a testosterone 6β-hydroxylase

    Journal of Biochemical and Molecular Toxicology

    Volume 15, Issue 2, 2001, Pages: 90–99, Ding Dai, Re Bai, Ernest Hodgson and Randy L. Rose

    Version of Record online : 27 MAR 2001, DOI: 10.1002/jbt.4

  4. You have free access to this content
    Expression of CYP3A in the Human Liver — Evidence that the Shift between CYP3A7 and CYP3A4 Occurs Immediately After Birth

    European Journal of Biochemistry

    Volume 247, Issue 2, July 1997, Pages: 625–634, Dan Lacroix, Michelle Sonnier, Arlette Moncion, Gérard Cheron and Thierry Cresteil

    Version of Record online : 16 JUL 2004, DOI: 10.1111/j.1432-1033.1997.00625.x

  5. An integrated pharmacokinetic model for the influence of CYP3A4 expression on the in vivo disposition of lopinavir and its modulation by ritonavir

    Journal of Pharmaceutical Sciences

    Volume 100, Issue 6, June 2011, Pages: 2508–2515, Rob ter Heine, Robert A. B. Van Waterschoot, Ron J. Keizer, Jos H. Beijnen, Alfred H. Schinkel and Alwin D. R. Huitema

    Version of Record online : 29 DEC 2010, DOI: 10.1002/jps.22457

  6. Cytochrome P450 3A expression and function in liver and intestinal mucosa from dexamethasone-treated sheep

    Journal of Veterinary Pharmacology and Therapeutics

    Volume 35, Issue 4, August 2012, Pages: 319–328, M. L. MATÉ, A. LIFSCHITZ, J. SALLOVITZ, M. BALLENT, A. S. MUSCHER, M. R. WILKENS, B. SCHRÖDER, C. LANUSSE and G. VIRKEL

    Version of Record online : 12 SEP 2011, DOI: 10.1111/j.1365-2885.2011.01334.x

  7. Cytochrome P450 Enzymes

    Preclinical Development Handbook: ADME and Biopharmaceutical Properties

    Eugene G. Hrycay, Stelvio M. Bandiera, Pages: 627–696, 2007

    Published Online : 27 AUG 2007, DOI: 10.1002/9780470249031.ch18

  8. Pharmacogenetic Pathway Analysis of Docetaxel Elimination

    Clinical Pharmacology & Therapeutics

    Volume 85, Issue 2, February 2009, Pages: 155–163, SD Baker, J Verweij, GA Cusatis, RH van Schaik, S Marsh, SJ Orwick, RM Franke, S Hu, EG Schuetz, V Lamba, WA Messersmith, AC Wolff, MA Carducci and A Sparreboom

    Version of Record online : 28 MAY 2008, DOI: 10.1038/clpt.2008.95

  9. Differentiation of intestinal and hepatic cytochrome P450 3A activity with use of midazolam as an in vivo probe: Effect of ketoconazole

    Clinical Pharmacology & Therapeutics

    Volume 66, Issue 5, November 1999, Pages: 461–471, Shirley M. Tsunoda, Rebecca L. Velez, Lisa L. von Moltke and David J. Greenblatt

    Version of Record online : 25 NOV 1999, DOI: 10.1016/S0009-9236(99)70009-3

  10. A mechanistic physiologically based pharmacokinetic-enzyme turnover model involving both intestine and liver to predict CYP3A induction-mediated drug–drug interactions

    Journal of Pharmaceutical Sciences

    Volume 102, Issue 8, August 2013, Pages: 2819–2836, Haifang Guo, Can Liu, Jia Li, Mian Zhang, Mengyue Hu, Ping Xu, Li Liu and Xiaodong Liu

    Version of Record online : 11 JUN 2013, DOI: 10.1002/jps.23613

  11. Functional Gene Variants of CYP3A4

    Clinical Pharmacology & Therapeutics

    Volume 96, Issue 3, September 2014, Pages: 340–348, A N Werk and I Cascorbi

    Version of Record online : 13 JUN 2014, DOI: 10.1038/clpt.2014.129

  12. CYP3A5 regulates prostate cancer cell growth by facilitating nuclear translocation of AR

    The Prostate

    Volume 75, Issue 5, April 1, 2015, Pages: 527–538, Ranjana Mitra and Oscar B. Goodman Jr

    Version of Record online : 13 JAN 2015, DOI: 10.1002/pros.22940

  13. You have free access to this content
    Clinical implementation of pharmacogenetics in kidney transplantation: calcineurin inhibitors in the starting blocks

    British Journal of Clinical Pharmacology

    Volume 77, Issue 4, April 2014, Pages: 715–728, Laure Elens, Rachida Bouamar, Nauras Shuker, Dennis A. Hesselink, Teun van Gelder and Ron H. N. van Schaik

    Version of Record online : 20 MAR 2014, DOI: 10.1111/bcp.12253

  14. Early postoperative erythromycin breath test correlates with hepatic cytochrome P4503A activity in liver transplant recipients

    Clinical Pharmacology & Therapeutics

    Volume 70, Issue 5, November 2001, Pages: 446–454, Lars E. Schmidt, Anette Kristensen Olsen, Karen Stentoft, Allan Rasmussen, Preben Kirkegaard and Kim Dalhoff

    Version of Record online : 5 NOV 2001, DOI: 10.1016/S0009-9236(01)36203-3

  15. Effects of enrofloxacin on cytochromes P4501A and P4503A in Carassius auratus gibelio (crucian carp)

    Journal of Veterinary Pharmacology and Therapeutics

    Volume 35, Issue 3, June 2012, Pages: 216–223, X. HU, X.-C. LI, B.-B. SUN, W.-H. FANG, S. ZHOU, L.-L. HU and J.-F. ZHOU

    Version of Record online : 4 JUL 2011, DOI: 10.1111/j.1365-2885.2011.01318.x

  16. Enzyme- and Transporter-Mediated Drug Interactions with Small Molecule Tyrosine Kinase Inhibitors

    Journal of Pharmaceutical Sciences

    Volume 103, Issue 12, December 2014, Pages: 3810–3833, Jie Shao, John S. Markowitz, Di Bei and Guohua An

    Version of Record online : 10 OCT 2014, DOI: 10.1002/jps.24113

  17. You have free access to this content
    Impact of genetic polymorphisms on tacrolimus pharmacokinetics and the clinical outcome of renal transplantation

    Transplant International

    Volume 25, Issue 4, April 2012, Pages: 471–480, Guillermo Gervasini, Montserrat Garcia, Rosa María Macias, Juan Jose Cubero, Francisco Caravaca and Julio Benitez

    Version of Record online : 28 FEB 2012, DOI: 10.1111/j.1432-2277.2012.01446.x

  18. Age-related Differences in CYP3A Abundance and Activity in the Liver of the Göttingen Minipig

    Basic & Clinical Pharmacology & Toxicology

    Volume 117, Issue 5, November 2015, Pages: 350–357, Els Van Peer, Lies De Bock, Koen Boussery, Jan Van Bocxlaer, Christophe Casteleyn, Chris Van Ginneken and Steven Van Cruchten

    Version of Record online : 18 MAY 2015, DOI: 10.1111/bcpt.12410

  19. Influence of CYP3A5 and MDR1 Genetic Polymorphisms on Urinary 6β-Hydroxycortisol/Cortisol Ratio After Grapefruit Juice Intake in Healthy Chinese

    The Journal of Clinical Pharmacology

    Volume 50, Issue 7, July 2010, Pages: 775–784, Dr Dan Li, Aziguli Abudula, Muhutar Abulahake, An-Ping Zhu, Ya-Qing Lou and Dr Guo-Liang Zhang

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270009354997

  20. You have free access to this content
    Identification, characterization, and ontogeny of a second cytochrome P450 3A gene from the fresh water teleost medaka (Oryzias latipes)

    Molecular Reproduction and Development

    Volume 58, Issue 2, February 2001, Pages: 149–158, Seth W. Kullman and David E. Hinton

    Version of Record online : 29 DEC 2000, DOI: 10.1002/1098-2795(200102)58:2<149::AID-MRD3>3.0.CO;2-X